Senseonics (NYSE:SENS) shares dipped slightly before hours today on third-quarter results that came in mixed compared to the consensus forecast. Shares of SENS fell 2.5% to 34¢ apiece in pre-market trading today. The Germantown, Maryland-based implantable continuous glucose monitor (CGM) maker reported losses of $23.98 million. That equals 4¢ per share on sales of $4.26 […]
Wall Street Beat
Insulet stock rises on Q3 beat, raised sales guidance
Insulet (Nasdaq:PODD) shares ticked up today on third-quarter results that came in well ahead of the consensus forecast. Shares of PODD rose 3.3% to $257 apiece in post-market trading today. The Acton, Massachusetts-based automated insulin delivery system maker reported profits of $77.5 million. That equals $1.08 per share on sales of $543.9 million for the […]
Tandem stock rises on 31% Q3 sales growth, raised guidance
Tandem Diabetes Care (Nasdaq:TNDM) shares ticked up after hours today on third-quarter results that topped the consensus forecast. Shares of TNDM rose 5% to $35.85 apiece in post-market trading today. The San Diego-based automated insulin delivery system maker reported losses of $23.3 million. That equals 35¢ per share on sales of nearly $244 million for […]
Phillips Medisize to buy inhaled drug delivery device maker Vectura from Philip Morris
Phillips Medisize parent company Molex announced that it agreed to acquire Vectura from a subsidiary of cigarette maker Philip Morris. Vectura designs and develops devices and formulations for inhaled drug delivery. Philip Morris paid $1.2 billion for the UK-based company in 2021 as part of its “Beyond Nicotine” effort to phase out cigarettes and develop […]
The 9 largest diabetes technology companies in the world
Diabetes technology comes in all shapes and sizes: insulin delivery systems, continuous glucose monitors and more. The companies that develop these technologies come in all shapes and sizes, too. Some focus entirely (or almost entirely) on solutions for people with diabetes. Others are much larger medtech firms that still have sizable business units that focus […]
Medtronic wants to be No. 1 in automated insulin delivery as Q1 results highlight Diabetes growth
Medtronic (NYSE:MDT) reported more growth in its Diabetes unit as the company’s recent moves signal its intent in the competitive insulin pump market. The company’s first-quarter (fiscal 2025) results included $647 million in revenue from the Diabetes unit. That marked 11% year-over-year growth from the same three-month period a year ago. U.S. revenues grew in […]
Embecta stock gets a boost on Q3 beats, patch pump program remains on track
Embecta (Nasdaq:EMBC) shares rose significantly today on third-quarter results that came in well ahead of the consensus forecast. Shares of EMBC ticked up 14% to $16.39 apiece in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose slightly. It’s the second recent boost for Embecta’s […]
Senseonics misses Q2 sales expectations but 365-day CGM is on track for Q4 launch
Senseonics (NYSE:SENS) shares dipped after hours today on second-quarter results that missed the consensus sales forecast. Shares of SENS fell 4% to 39¢ apiece in post-market trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the day up nearly 1%. The Germantown, Maryland-based long-term implantable […]
Insulet reports Omnipod sales growth of 26% in Q2, raises guidance despite EPS miss
Insulet (Nasdaq:PODD) stock is down on second-quarter results that came in mixed compared to the consensus forecast. Shares of PODD were down more than 7% to $184.56 apiece by midday trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up slightly. Yesterday evening, the Acton, […]
Tandem stock soars after hours on Q2 beats, increased guidance as pump shipments rise again
Tandem Diabetes Care (Nasdaq:TNDM) shares got a boost after the market closed today on second-quarter results that beat the consensus forecast. Shares of TNDM rose more than 22% to $43.20 apiece in post-market trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — closed the day down […]
